Yahoo Web Search

Search results

  1. Daphne Koller is CEO and Founder of insitro, a machine learning-enabled drug discovery company. She is also co-founder of Engageli, a digital learning plat...

  2. www.insitro.com › leadership › daphne-kollerDaphne Koller - insitro

    Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients.

  3. Daphne Koller is the CEO and founder of insitro, a machine learning–enabled drug discovery company. Daphne is also the co-founder of Engageli, was the Rajeev...

  4. Feb 20, 2013 · This former Stanford University professor’s cutting edge work combines machine learning and biology to transform pharmaceutical drug development. Her work at...

  5. View Daphne Kollers profile on LinkedIn, a professional community of 1 billion members.

    • 500+
    • 15K
    • insitro
    • San Francisco Bay Area
  6. Nov 11, 2019 · Daphne Koller, A Star Professor—And Her Radical, AI-Powered Plan To Discover New Drugs ... Join Us; info@insitro.com. 279 East Grand Avenue South San Francisco ...

  7. Oct 25, 2023 · Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI technology is able to analyze images of cancerous tissue, a ...

  1. People also search for